Emmanuel T. Akporiaye
Affiliations: | Microbiology & Immunology | University of Arizona, Tucson, AZ |
Area:
Immunology, OncologyGoogle:
"Emmanuel Akporiaye"Children
Sign in to add trainee| Rita S. Wu | grad student | 2001 | University of Arizona |
| James J. Kobie | grad student | 2003 | University of Arizona |
| Lalitha Ramanathapuram | grad student | 2006 | University of Arizona |
| Matthew Rausch | grad student | 2008 | University of Arizona |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Redmond WL, Kasiewicz MJ, Akporiaye ET. (2023) Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA. Frontiers in Immunology. 14: 1057702 |
| Guerrouahen BS, Maccalli C, Cugno C, et al. (2019) Reverting Immune Suppression to Enhance Cancer Immunotherapy. Frontiers in Oncology. 9: 1554 |
| Polanczyk MJ, Walker E, Haley D, et al. (2019) Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4CD25Foxp3 and CD4CD25Foxp3 T cells. Journal of Translational Medicine. 17: 219 |
| Crittenden MR, Baird J, Friedman D, et al. (2016) Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy. Oncotarget |
| Althammer S, Steele K, Rebelatto M, et al. (2016) 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts Journal For Immunotherapy of Cancer. 4 |
| Triplett TA, Tucker CG, Triplett KC, et al. (2015) STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade. Cancer Immunology Research. 3: 526-35 |
| Young KH, Newell P, Cottam B, et al. (2014) TGFβ inhibition prior to hypofractionated radiation enhances efficacy in preclinical models. Cancer Immunology Research. 2: 1011-22 |
| Hahn T, Akporiaye ET. (2013) α-TEA as a stimulator of tumor autophagy and enhancer of antigen cross-presentation. Autophagy. 9: 429-31 |
| Hahn T, Polanczyk MJ, Borodovsky A, et al. (2013) Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors. Current Pharmaceutical Biotechnology. 14: 357-76 |
| Akporiaye ET, Tucker C, Triplett T, et al. (2013) STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors Journal For Immunotherapy of Cancer. 1 |